Thrilled to share that my abstract is selected for the European Atherosclerosis Society 92nd Congress to be held in Lyon, France next month. Looking forward to presenting and connecting with colleagues in this exciting field! European Atherosclerosis Society EAS Congress Atherosclerosis Atherosclerosis Plus
Will cholesterol-busting #genetherapy become the ‘true inheritor’ of statins?
Following compelling preclinical results, Repair Bio’s #cholesterol -degrading platform is gearing up for clinical trials in #atherosclerosis .
#longevity
longevity.technology/news/will-chol…
Coronary Plaque in Athletes
mdpi.com/2077-0383/13/7…
#athletes #atherosclerosis #excersize #SportsCardiology
Outstanding presentation by Taryn Youngstein at #BSR24 on treatment, claudication management and the risk of cardiovascular disease in large vessel #Vasculitis . Be aware of subclinical #atherosclerosis .
BSR #CardioRheum
#Rheumatology
This review summarizes the findings of recent studies and discusses the role of #mitochondrial dysfunction in the risk factors and critical cells of #atherosclerosis .
sciencedirect.com/science/articl…
Chronic #inflammation can contribute to #atherosclerosis , increasing risk of heart attacks & strokes
REMEDY: #Turmeric contains anti-inflammatory curcumin & can reduce inflammation, help cardiovascular function & #arthritis & inflammatory bowel disease
organiclivefood.com/health/10waysc…
Removing Progerin (pathogenic Lamin A variant in #HutchinsonGilfordProgeriaSyndrome ) from #SmoothMuscleCell (SM22α-Cre, so cardiomyocyte as well?🧐), but not #EndothelialCell (Cdh5-Cre), ⏬progeroid HGPSrev🐭 #Atherosclerosis (AAV8-PCSK9)
Aortic medial collagen is almost depleted
Just realized it’s only one month ahead for the #EASCongress2024 - cannot wait to meet you all in Lyon!
#atherosclerosis #cardiovascular
TREM2 as a positive regulator of Macrophage #FoamCell mitochondrial function, survival & efferocytosis under hypercholesterolemic stress
Hematopoietic TREM2 KO⏫ #NecroticCore formation in early (8~12 wk), not late (16~20 wk) #Atherosclerosis in Ldlr-/-🐭
w/o altering lesion or